Table of Contents

<< Previous Issue

Feb 2014 (Vol: 2014, Issue: 2)

Next Issue >>

Download pdf of entire issue

Section: Licensing
Genzyme Invests US$700 M in Alnylam in Sign of Resurgent Interest in RNAi Therapeutics Published: 11 Feb-2014
By: Heather Cartwright
Abstract Fulltext:
Section: Mergers & Acquisitions
The Carlyle Group Offers US$4.15 B for J&J’s Ortho-Clinical Diagnostics Published: 10 Feb-2014
By: Heather Cartwright
Abstract Fulltext:
Par Pharmaceutical Targets US Injectables Market with JHP Pharmaceuticals Purchase Published: 15 Feb-2014
By: Heather Cartwright
Abstract Fulltext:
Teva Outbids Endo to Secure NuPathe Acquisition Published: 19 Feb-2014
By: Heather Cartwright
Abstract Fulltext:
Section: Research & Development
Biogen Idec Enters Genome-Editing Field with Sangamo BioSciences Collaboration Published: 4 Feb-2014
By: Heather Cartwright
Abstract Fulltext:
Santaris’ RNA-Targeting Platform Delivers Three Deals in Three Days Published: 7 Feb-2014
By: Heather Cartwright
Abstract Fulltext:
Edison and Dainippon Sumitomo Broaden Relationship with Discovery Alliance Targeting Redox Biochemistry Published: 22 Feb-2014
By: Heather Cartwright
Abstract Fulltext:
Ablynx and Merck & Co. Expand Alliance with US$2.3 B Cancer Immunotherapy Discovery Deal Published: 28 Feb-2014
By: Heather Cartwright
Abstract Fulltext:

Login

Login

Username:

Password:

Keep me logged in

Login Problems? Subscribe

IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents